Arkolith/Insider Trading/MIRO/Form 4

Ross Jeffrey James

CHIEF EXECUTIVE OFFICER, DirectorMiromatrix Medical Inc. (MIRO) · full profile →Form 4 · filed Mar 17, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 15, 2022Option exercise(M)35K$1.25$44K294K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 15, 2022Option exercise(M)35K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-22-003137) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML